Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Researchers made a special butter with added betasitosterol that could be healthier for the heart and stayed good for three months.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Retinoic acid may help heal skin without scars by reducing fibrosis and supporting skin regeneration.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

CS12192 effectively treats alopecia areata with better safety than current options.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Sinapic acid may help fight obesity and promote hair growth.

Both steroid and vitamin D3 treatments are safe and effective for patchy alopecia areata, with steroids showing slightly better results.